The PSMA-inhibitor 2-PMPA markedly reduced the tumor accumulation of the Zr-89-labeled PSMA-targeting vector (F(1,4) = 10.3, p = 0.0324, post hoc p < 0.05 after 1 h). The gene discussed is FOLH1; the disease is neoplasm.